Patent Assignment
Reel/Frame 027270/0799
Security Agreement
Recorded: 2011-11-21
Pages: 13
Assignors
MYLAN PHARMACEUTICALS, INC.
Executed: 2011-11-14
MYLAN BERTEK PHARMACEUTICALS INC.
Executed: 2011-11-14
MYLAN TECHNOLOGIES, INC.
Executed: 2011-11-14
MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.)
Executed: 2011-11-14
SOMERSET PHARMACEUTICALS, INC.
Executed: 2011-11-14
DEY PHARMA, L.P. (F/K/A DEY L.P.)
Executed: 2011-11-14
Assignee
BANK OF AMERICA, N.A., AS COLLATERAL AGENT
101 N TRYON STREET, NC1-001-05-45, ONE INDEPENDENCE CENTER, CHARLOTTE, NORTH CAROLINA, USA 28255-0001
Covered Properties
(99)
Treatment of Macular Degeneration
Patent:
5,242,950 →
Application:
07/872,839 →
Retinoic Acid-Containing Polyether-Polyurethane Compositions
Patent:
5,650,171 →
Application:
07/875,772 →
Packaging System for Medication
Patent:
5,242,055 →
Application:
07/982,484 →
Foam Laminate Transdermal Patch
Patent:
5,503,844 →
Application:
08/063,515 →
Adhesive Dressing Applicator
Patent:
5,840,052 →
Application:
08/379,863 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
5,662,926 →
Application:
08/426,492 →
Packaging System for Medication
Patent:
35,445 →
Application:
08/445,778 →
Foam Laminate Transdermal Patch
Patent:
5,629,014 →
Application:
08/476,418 →
Process of Assembling a Transdermal Patch Incorporation a Polymer Film Incorporated with an Active Agent
Patent:
5,679,373 →
Application:
08/477,042 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
5,676,969 →
Application:
08/477,312 →
S(+) Desmethylselegiline and Its Use in Therapeutic Methods and Pharmaceutical Compositions
Patent:
6,033,682 →
Application:
08/679,328 →
Retinoic Acid-Containing Compositions
Patent:
5,700,483 →
Application:
08/708,181 →
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Transdermal Patch
Patent:
5,948,433 →
Application:
08/918,526 →
Antifungal/Steroid Topical Compositions
Patent:
6,075,056 →
Application:
08/943,574 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
6,010,715 →
Application:
08/954,861 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and an Inorganic Acid Stabilizer
Patent:
5,968,553 →
Application:
09/000,673 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Patent:
6,221,917 →
Application:
09/000,999 →
Sublingual and Buccal Administration of Selegiline for Treating Certain Selegiline-Responsive Diseases and Conditions
Patent:
6,117,912 →
Application:
09/066,916 →
Polyurethanes as Topical Skin Protectants
Patent:
6,277,364 →
Application:
09/169,208 →
Stabilized Injectable Pharmaceutical Compositions Containing Taxoid Anti-Neoplastic Agents
Patent:
6,071,952 →
Application:
09/203,350 →
Phenytoin Sodium Pharmaceutical Compositions
Patent:
6,274,168 →
Application:
09/255,705 →
Use of Vitamin D Analogs to Treat Conditions Related to Increased Oxidative Stress
Patent:
6,262,041 →
Application:
09/287,544 →
Topical Formulations for the Treatment of Nail Fungal Diseases
Patent:
6,143,794 →
Application:
09/289,205 →
Method for Preventing and Treating Peripheral Neurophathy by Administering Selegiline
Patent:
6,239,181 →
Application:
09/402,752 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Patent:
6,242,496 →
Application:
09/406,906 →
Stabilized Injectable Pharmaceutical Compositions Containing Taxoid Anti-Neoplastic Agents
Patent:
6,153,644 →
Application:
09/432,084 →
S(+) Desmethylselegiline and Its Use in Therapeutic Methods and Pharmaceutical Compositions
Patent:
6,210,706 →
Application:
09/448,483 →
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Universal Adapter with Interchangeable Plugs
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Phenytoin Sodium Pharmaceutical Compositions
Bronchodilating Compositions and Methods
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Albuterol Inhalation Solution, System, Kit and Method for Relieving Symptoms of Pediatric Asthma
Bronchodilating Compositions and Methods
Albuterol and Ipratropium Inhalation Solution, System, Kit and Method for Relieving Symptoms of Chronic Obstructive Pulmonary Disease
Methods for Treating Photodamaged Skin by Administering Selegiline or Desmethylselegiline
S(+) Desmethylselegiline and Its Use to Treat Adhd
Method for Preventing and Treating Peripheral Neuropathy by Administering Selegiline
Nasal pharmaceutical formulations and methods of using the same
Nasal Pharmaceutical Formulations and Methods of Using the Same
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Transdermal Patch Incorporating Active Agent Migration Barrier Layer
Formulations and methods for treating rhinosinusitis
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
Application:
10/795,584 →
Publication:
US 2005/0202073
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
Application:
10/800,031 →
Publication:
US 2005/0202079
Bronchodilating Beta-Agonist Compositions and Methods
Albuterol and Ipratropium Inhalation Solution, System, Kit and Method for Relieving Symptoms of Chronic Obstructive Pulmonary Disease
Formulations and Methods for Treating Rhinosinusitis
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Fluticasone Propionate Nasal Pharmaceutical Formulations and Methods of Using Same
Beclomethasone Dipropionate Monohydrate Nasal Pharmaceutical Formulations and Methods of Using the Same
Formulations and Methods for Treating Rhinosinusitis
Two-Sided Non-Stick Release Film
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
Application:
11/541,523 →
Long-Wearing Removable Pressure Sensitive Adhesive
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Application:
11/723,111 →
Publication:
US 2007/0166365
Amorphous drug transdermal systems, manufacturing methods, and stabilization
Application:
11/725,159 →
Publication:
US 2008/0226698
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Application:
11/743,411 →
Publication:
US 2007/0259027
Drug Formulations Having Inert Sealed Cores
Stabilized Tolterodine Tartrate Formulations
Transdermal drug delivery systems comprising a coated release liner
Nasal Pharmaceutical Formulations and Methods of Using the Same
Application:
11/931,380 →
Publication:
US 2008/0050442
Nasal Pharmaceutical Formulations and Methods of Using the Same
Formulations and Methods for Treating Rhinosinusitis
Formulation and Method for the Release of Paroxetine in the Large Intestine
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery
Controlled Release Budesonide Minitablets
Controlled Release Budesonide Minitablets
Extended Release Formulation Containing a Wax
Application:
12/406,272 →
Publication:
US 2009/0238873
Transdermal systems having control delivery system
Application:
12/454,782 →
Publication:
US 2009/0234308
Stabilized Transdermal Drug Delivery System
Amorphous Rotigotine Transdermal System
Application:
12/571,509 →
Publication:
US 2010/0086582
Method for Making a Multilayer Adhesive Laminate
Adhesive mixture for transdermal delivery of highly plasticizing drugs
Application:
12/589,380 →
Publication:
US 2010/0040690
Formoterol/Steroid Bronchodilating Compositions and Methods of Use Thereof
Nebulizable Compositions of Quaternary Ammonium Muscarinic Receptor Antagonists
Application:
12/704,767 →
Publication:
US 2010/0143375
Bronchodilating Beta-Agonist Compositions and Methods
Controlled Release Levetiracetam Formulations and Methods for Producing the Same
Process for the Continuous Manufacture of a Polyisobutylene Based Transdermal Patch
Extended-Release Dosage Form
Application:
12/977,713 →
Publication:
US 2011/0123613
Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery
Stabilized Transdermal Drug Delivery System
Application:
12/994,918 →
Publication:
US 2011/0182949
Long-Wearing Removable Pressure Sensitive Adhesive
Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same
Application:
13/020,429 →
Publication:
US 2011/0265786
Formoterol/Steroid Bronchodilating Compositions and Methods of Use Thereof
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery
Disintegrable Formulations of Lanthanum Carbonate
Albuterol and Ipratropium Inhalation Solution, System, Kit and Method for Relieving Symptoms of Chronic Obstructive Pulmonary Disease
Application:
13/160,009 →
Publication:
US 2011/0247613
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Nov 18, 2011
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MYLAN TECHNOLOGIES, INC.; DEY, INC. (F/K/A DEY LABORATORIES, INC.); MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN PHARMACEUTICALS, INC.
Reel/Frame 027261/0928 →
Change of Name
Dec 8, 2011
From: BERTEK PHARMACEUTICALS INC.
To: MYLAN BERTEK PHARMACEUTICALS INC.
Reel/Frame 027354/0019 →
Change of Name
Dec 8, 2011
From: UDL LABORATORIES, INC.
To: MYLAN INSTITUTIONAL
Reel/Frame 027347/0689 →
Change of Name
Dec 9, 2011
From: BERTEK, INC.
To: MYLAN TECHNOLOGIES, INC.
Reel/Frame 027361/0926 →
Change of Name
Dec 10, 2011
From: UDL LABORATORIES, INC.
To: MYLAN INSTITUTIONAL
Reel/Frame 027370/0119 →
Change of Name
Dec 10, 2011
From: MLI ACQUISITION CORP. II
To: BERTEK, INC.
Reel/Frame 027370/0121 →
Assignment of Assignor's Interest
Dec 10, 2011
From: KWIATEK, ALFRED; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.; GOVIL, SHARAD K.
To: MLI ACQUISITION CORP. II
Reel/Frame 027370/0031 →
Assignment of Assignor's Interest
Dec 10, 2011
From: BERTEK, INC.
To: MLI ACQUISITION CORP. II
Reel/Frame 027370/0039 →
Change of Name
Dec 10, 2011
From: BERTEK, INC.
To: MYLAN TECHNOLOGIES, INC.
Reel/Frame 027370/0113 →
Assignment of Assignor's Interest
Dec 10, 2011
From: PORA, RAYMOND I.
To: UDL LABORATORIES, INC.
Reel/Frame 027368/0173 →
Assignment of Assignor's Interest
Dec 10, 2011
From: WICK, JOHN; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.
To: BERTEK, INC.
Reel/Frame 027368/0761 →
Assignment of Assignor's Interest
Dec 11, 2011
From: WICK, JOHN; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.
To: BERTEK, INC.
Reel/Frame 027362/0544 →
Assignment of Assignor's Interest
Dec 11, 2011
From: BERTEK, INC.
To: MLI ACQUISITION CORP. II
Reel/Frame 027362/0551 →
Change of Name
Dec 11, 2011
From: MLI AQUISITION CORP. II
To: BERTEK, INC.
Reel/Frame 027363/0462 →
Change of Name
Dec 13, 2011
From: BERTEK PHARMACEUTICALS INC.
To: MYLAN BERTEK PHARMACEUTICALS INC.
Reel/Frame 027377/0025 →
Patent Release
Dec 10, 2012
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: DEY PHARMA L.P. (F/K/A DEY, L.P.); MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.
Reel/Frame 029440/0967 →
Assignment of Assignor's Interest
Dec 29, 2022
From: GOMES DA COSTA, EVERTON
To: NICOLAAS JOSEF SCHOENMAKER E OUTROS
Reel/Frame 062237/0116 →